TY - JOUR
T1 - Engineered Bacteria for Cholera Prophylaxis
AU - Satchell, Karla J.F.
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/8/8
Y1 - 2018/8/8
N2 - Over 1.3 billion persons are at risk for cholera globally. Vaccination campaigns are growing, but intervention options providing nearly immediate protection are also needed. Two recent papers in Science Translational Medicine describe probiotic bacteria that reduce intestinal colonization in animal models and show promise for development as prophylaxis agents. Over 1.3 billion persons are at risk for cholera globally. Vaccination campaigns are growing, but intervention options providing nearly immediate protection are also needed. Two recent papers in Science Translational Medicine describe probiotic bacteria that reduce intestinal colonization in animal models and show promise for development as prophylaxis agents.
AB - Over 1.3 billion persons are at risk for cholera globally. Vaccination campaigns are growing, but intervention options providing nearly immediate protection are also needed. Two recent papers in Science Translational Medicine describe probiotic bacteria that reduce intestinal colonization in animal models and show promise for development as prophylaxis agents. Over 1.3 billion persons are at risk for cholera globally. Vaccination campaigns are growing, but intervention options providing nearly immediate protection are also needed. Two recent papers in Science Translational Medicine describe probiotic bacteria that reduce intestinal colonization in animal models and show promise for development as prophylaxis agents.
UR - http://www.scopus.com/inward/record.url?scp=85050537614&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050537614&partnerID=8YFLogxK
U2 - 10.1016/j.chom.2018.07.013
DO - 10.1016/j.chom.2018.07.013
M3 - Short survey
C2 - 30092195
AN - SCOPUS:85050537614
SN - 1931-3128
VL - 24
SP - 192
EP - 194
JO - Cell Host and Microbe
JF - Cell Host and Microbe
IS - 2
ER -
